LIFE-B:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund UnHedged Units (CAD)

ETF | Others |

Last Closing

CAD 24.33

Change

+0.04 (+0.16)%

Market Cap

CAD 0.01B

Volume

501.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

N/A

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.45 (+0.71%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.18 (+0.85%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.17 (+0.58%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

+0.09 (+1.01%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

+0.02 (+0.14%)

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.09 (+0.42%)

CAD 2.78B

ETFs Containing LIFE-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.27% 49% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.27% 48% F 44% F
Trailing 12 Months  
Capital Gain -4.92% 10% F 27% F
Dividend Return 1.25% 60% D- 21% F
Total Return -3.67% 13% F 25% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.82% 62% D 50% F
Dividend Return 1.88% 62% D 45% F
Total Return 0.06% 59% D- 13% F
Risk Return Profile  
Volatility (Standard Deviation) 5.37% 71% C- 87% B+
Risk Adjusted Return 34.99% 71% C- 62% D
Market Capitalization 0.01B 23% F 9% A-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.